Metabolic dysfunction- associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults afflicted by ...

Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- The "Human Liver Model Market: 2026 Edition" report has been added to ResearchAndMarkets.com's offering. The global human liver model market value in 2024 ...

A stained micrograph of 3D primary human liver cell tissue modeling MASH. Areas of fibrosis are indicated in blue. Image courtesy of Viscient Biosciences. Metabolic dysfunction- associated ...

In a bid to gain further understanding of the etiology and pathogenesis of metabolic dysfunction–associated steatohepatitis (MASH), a team of researchers has created 3D bioprinted liver models. MASH, ...

A US biotechnology company has 3D printed a tiny functioning liver in the lab that survived just over five days -- more than twice the life expectancy of 2D versions. Presenting the results at the ...

Bengaluru: IIT-Madras aerospace engineer Suhridh Sundaram founded his 3D printing biotech startup with six ambitious words. “Macha (brother), let us print human organs,” he told his business partner ...

JMIR Publications released a story on how 3D-printed anatomical models are being used to improve surgical outcomes in its ...

Metabolic dysfunction--associated steatohepatitis or MASH (formerly known as nonalcoholic steatohepatitis) is an inflammatory, liver-scarring disease that affects 1.5% to 6.5% of all U.S. adults.